TAK technical analysis
TAK Technical Analysis
Analysis date
July 15, 2026
Market
NYSE (USD)
Daily cutoff
July 14, 2026
Reliability
Passed
Informational use only. This page is not investment advice.
Data verification
TAK Data Verification
Cross-validating the latest completed daily bar across independent sources.
- Symbol
- TAK
- Market
- NYSE
- Currency
- USD (US Dollar)
- Latest completed bar
- July 14, 2026
No adjustment factor (adjusted close equals raw close, factor 1.0). No stock splits or dividend adjustments affecting the analysis period.
| Source | Latest Close | Date | Difference | Status |
|---|---|---|---|---|
| Yahoo Finance Chart API (primary) | 15.28 | July 14, 2026 | - | Verified |
| Finviz (independent) | 15.28 | July 14, 2026 (previous close) | 0.00% | Verified |
Bottom line
TAK Technical Analysis Summary
TAK (Takeda Pharmaceutical) presents a cautiously improving technical picture after a prolonged period of consolidation. On the daily chart, price at 15.28 has reclaimed SMA20 (14.92) and is testing SMA50 (15.01), suggesting short-term momentum is shifting positively. However, price remains below SMA200 (16.08), confirming the longer-term trend is still bearish. RSI14 at 54.73 indicates bullish momentum is building without overbought conditions. The daily MACD has generated a bullish crossover with the MACD line crossing above the signal line, and the histogram at 0.08 is positive — a constructive early signal. The weekly timeframe remains in a downtrend with price below all key SMAs, though RSI at 46.89 has moved toward the 50 midline from oversold levels. Key resistance sits at SMA200 (16.08) and the 60-day high (16.15). Support rests at the 20-day low of 14.43 and the 60-day low of 13.77. A sustained move above 16.08 would be needed to shift the long-term trend from bearish to neutral.
Multi-timeframe dashboard
Multi-Timeframe Technical Dashboard
Comparing daily (2-year) and weekly (5-year) perspectives to identify aligned or conflicting signals.
Daily (July 14, 2026)
- Trend
- Improving but mixed. Price at 15.28 is above SMA20 (14.92, +2.41%) and testing SMA50 (15.01, +1.80%) but remains below SMA200 (16.08, -4.98%). This indicates short-term momentum has improved but the stock has not yet reclaimed its long-term moving average. SMA20 is sloping upward while SMA200 continues to decline slowly.
- Momentum
- Bullish with improving bias. RSI14 at 54.73 is above the 50 midline, indicating bullish momentum without overbought conditions. MACD line at 0.04 has crossed above the signal line at -0.04, and the histogram at 0.08 is positive — a modest but constructive bullish crossover signal suggesting momentum is shifting in favor of the bulls.
- Volatility
- Low to moderate. ATR14 at 0.28 (1.83% of price) suggests typical daily movement for a large-cap pharmaceutical stock. Bollinger Bands (14.43 to 15.72) show price near the upper band, consistent with the recent upward move. Band width is narrow, indicating contracting volatility.
- Volume
- Below average. Latest volume of 2,189,400 is 67.2% of the 20-period average (3,256,700), indicating reduced participation. The recent rally lacks strong volume confirmation, which warrants caution.
Assessment
The daily chart shows a positive development with TAK reclaiming SMA20 and testing SMA50. The bullish MACD crossover is a technically meaningful near-term signal. However, the stock remains in a longer-term downtrend as confirmed by the declining SMA200 and price below it. Volume has been lackluster during the rally, reducing conviction. The 52-week position at 36.7% reflects the stock is in the lower half of its annual range. A decisive move above SMA200 (16.08) would be a meaningful trend change signal.
Weekly (July 6, 2026 week)
- Trend
- Bearish with early improvement signs. Price at 15.26 is below SMA20 (15.86), SMA50 (16.13), and SMA200 (16.10). All major moving averages are closely clustered between 15.86 and 16.13, suggesting a period of consolidation. The SMA20 is flattening but SMA50 and SMA200 continue to slope slightly downward.
- Momentum
- Neutral with improving bias. RSI14 at 46.89 has moved toward the 50 midline from oversold levels, a notable shift from the sub-40 readings seen earlier. MACD line at -0.05 is flattening toward the signal line at -0.08, and the histogram at 0.03 is barely positive, suggesting deteriorating bearish momentum.
- Volatility
- Low. ATR14 at 0.49 (3.21% of price) reflects typical weekly ranges for a large-cap pharma stock. Bollinger Bands (14.64 to 17.14) are relatively narrow, reflecting the extended consolidation phase.
- Volume
- Slightly below average. Weekly volume of 9,875,300 is 88.4% of the 20-week average (11,167,500), indicating normal to slightly reduced participation levels.
Assessment
The weekly chart still reflects a bearish structure with price below all major SMAs. However, the cluster of moving averages between 15.86 and 16.13 represents a significant resistance zone that, if broken, could trigger a trend change. The RSI recovery toward 50 and the flattening MACD suggest the downtrend may be losing steam. The stock has been consolidating between roughly 13.77 and 16.15 for several months. A weekly close above 16.15 (60-week and 52-week high) would be a meaningful breakout signal.
Key indicators
TAK Key Technical Indicators
RSI, MACD, moving averages, ATR, and Bollinger Bands across daily and weekly timeframes.
| Indicator | Daily | Weekly |
|---|---|---|
| RSI (14) | 54.73 | 46.89 |
| MACD (12, 26, 9) | 0.04 / -0.04 / 0.08 | -0.05 / -0.08 / 0.03 |
| ATR (14) | 0.28 (1.83%) | 0.49 (3.21%) |
| Bollinger Bands (20, 2) | 14.43 - 15.72 | 14.64 - 17.14 |
| SMA (20) | 14.92 | 15.86 |
| SMA (50) | 15.01 | 16.13 |
| SMA (200) | 16.08 | 16.10 |
Price structure
TAK Price Structure and Returns
Price performance across multiple lookback periods and 52-week position.
| Metric | Daily | Weekly |
|---|---|---|
| Current Price | 15.28 | 15.26 |
| 1-Period Return | +0.86% | +1.73% |
| 5-Period Return | +2.34% | +3.46% |
| 20-Period Return | +4.16% | +2.97% |
| 60-Period Return | +8.52% | +4.95% |
| 252-Period Return | -3.54% | -6.27% |
| 52-Week Low | 13.28 | 13.28 |
| 52-Week High | 16.15 | 16.15 |
| 52-Week Position | 36.70% | 36.20% |
Key levels
TAK Support and Resistance Levels
Key price levels based on recent swing highs and lows across daily and weekly timeframes.
| Level | Daily | Weekly |
|---|---|---|
| 20-Period High | 15.72 | 17.14 |
| 20-Period Low | 14.43 | 14.64 |
| 60-Period High | 16.15 | 16.15 |
| 60-Period Low | 13.77 | 13.28 |
Scenarios
TAK Technical Scenarios
Conditions, invalidation triggers, and what to watch for each scenario.
Bullish
Trigger
Price breaks above the SMA200 (16.08) and the 60-day/52-week high of 16.15 with above-average volume.
Invalidation
Price falls back below SMA20 (14.92) and breaks the 20-day low at 14.43.
What to watch
Daily RSI holding above 55; MACD histogram continuing to expand; weekly RSI crossing above 50; volume increasing on break attempts.
Range-Bound
Trigger
Price continues to oscillate between the 20-day low of 14.43 and the 60-day high of 16.15 with no clear directional bias.
Invalidation
A decisive break above 16.15 or below 14.43 with increasing volume.
What to watch
RSI staying between 45 and 55; MACD histogram fluctuating around zero; volume remaining near or below average.
Bearish
Trigger
Price fails to hold above SMA50 (15.01) and breaks below the 20-day low at 14.43, resuming the longer-term downtrend.
Invalidation
Price reclaims and holds above SMA20 (14.92) and establishes a higher low above 14.43.
What to watch
Daily RSI falling below 50; MACD histogram turning negative; volume increasing on down days; weekly RSI dropping back below 40.
Methodology
Methodology and Limitations
This technical analysis uses adjusted closing prices from Yahoo Finance (primary) and Finviz (independent cross-validation). The daily analysis covers approximately 2 years (501 completed bars) ending July 14, 2026. The weekly analysis covers approximately 5 years (261 completed bars) ending the week of July 6, 2026. Prices are adjusted for dividends and stock splits using the adjusted close/raw close ratio. Volume data is from the primary source and may not match other data providers. Technical indicators include SMA, RSI, MACD, ATR, and Bollinger Bands using standard parameters. Key levels are identified from recent swing highs and lows. Technical analysis studies historical price patterns and does not constitute investment advice. It should not be used as the sole basis for trading decisions.
Frequently Asked Questions
This technical analysis is for informational and educational purposes only. It does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Past performance and historical patterns are not guarantees of future results. All investments carry risk, including the potential loss of principal. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data sourced from Yahoo Finance (primary) and Finviz (independent cross-validation). Data cutoffs: daily July 14, 2026, weekly July 6, 2026 week. Generated July 15, 2026.
Related Tools
AI Chart Analyzer
Upload a TradingView chart screenshot and get instant AI-powered technical analysis. Identify patterns, support and resistance, and key levels.
Support and Resistance Calculator
Calculate key support and resistance levels for any stock. Identify potential price zones where reversals or breakouts may occur.
RSI Calculator
Calculate the Relative Strength Index for any stock. Determine overbought and oversold conditions with customizable periods.